Oppenheimer Asset Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.14M | Buy |
35,128
+17,203
| +96% | +$2.4M | 0.05% | 373 |
|
|
2025
Q4 | $2.94M | Buy |
17,925
+1,077
| +6% | +$169K | 0.04% | 425 |
|
|
2025
Q3 | $2.25M | Sell |
16,848
-599
| -3% | -$72.8K | 0.02% | 535 |
|
|
2025
Q2 | $2.17M | Sell |
17,447
-2,237
| -11% | -$285K | 0.02% | 529 |
|
|
2025
Q1 | $2.5M | Buy |
19,684
+2,117
| +12% | +$326K | 0.03% | 467 |
|
|
2024
Q4 | $2.53M | Sell |
17,567
-3,418
| -16% | -$490K | 0.03% | 473 |
|
|
2024
Q3 | $3.12M | Buy |
20,985
+1,411
| +7% | +$202K | 0.04% | 432 |
|
|
2024
Q2 | $2.47M | Buy |
19,574
+2,783
| +17% | +$436K | 0.03% | 473 |
|
|
2024
Q1 | $3.09M | Sell |
16,791
-693
| -4% | -$132K | 0.05% | 377 |
|
|
2023
Q4 | $3.14M | Sell |
17,484
-435
| -2% | -$67.7K | 0.04% | 401 |
|
|
2023
Q3 | $2.85M | Buy |
17,919
+1,665
| +10% | +$272K | 0.04% | 392 |
|
|
2023
Q2 | $2.3M | Buy |
16,254
+12,453
| +328% | +$2M | 0.03% | 462 |
|
|
2023
Q1 | $640K | Sell |
3,801
-2
| -0.1% | -$357 | 0.01% | 783 |
|
|
2022
Q4 | $644K | Sell |
3,803
-180
| -5% | -$32.6K | 0.01% | 782 |
|
|
2022
Q3 | $745K | Sell |
3,983
-577
| -13% | -$122K | 0.01% | 741 |
|
|
2022
Q2 | $741K | Sell |
4,560
-19,394
| -81% | -$3.07M | 0.01% | 762 |
|
|
2022
Q1 | $4.51M | Buy |
23,954
+3,665
| +18% | +$696K | 0.06% | 313 |
|
|
2021
Q4 | $5.37M | Sell |
20,289
-598
| -3% | -$161K | 0.07% | 293 |
|
|
2021
Q3 | $6.04M | Buy |
20,887
+16,951
| +431% | +$4.35M | 0.09% | 274 |
|
|
2021
Q2 | $786K | Buy |
3,936
+9
| +0.2% | +$1.75K | 0.01% | 818 |
|
|
2021
Q1 | $763K | Buy |
3,927
+82
| +2% | +$16.8K | 0.01% | 803 |
|
|
2020
Q4 | $737K | Buy |
3,845
+163
| +4% | +$29.7K | 0.01% | 778 |
|
|
2020
Q3 | $543K | Buy |
3,682
+205
| +6% | +$29.3K | 0.01% | 791 |
|
|
2020
Q2 | $430K | Buy |
3,477
+798
| +30% | +$93.9K | 0.01% | 829 |
|
|
2020
Q1 | $258K | Buy |
2,679
+597
| +29% | +$57.6K | 0.01% | 910 |
|
|
2019
Q4 | $193K | Sell |
2,082
-83
| -4% | -$6.97K | ﹤0.01% | 1070 |
|
|
2019
Q3 | $166K | Sell |
2,165
-56
| -3% | -$4.9K | ﹤0.01% | 1079 |
|
|
2019
Q2 | $190K | Sell |
2,221
-164
| -7% | -$11.2K | ﹤0.01% | 1060 |
|
|
2019
Q1 | $141K | Buy |
2,385
+292
| +14% | +$16.8K | ﹤0.01% | 1128 |
|
|
2018
Q4 | $110K | Buy |
+2,093
| New | +$123K | ﹤0.01% | 1169 |
|
|
2017
Q4 | – | Sell |
-2,942
| Closed | -$113K | – | 1399 |
|
|
2017
Q3 | $113K | Sell |
2,942
-20
| -0.7% | -$838 | ﹤0.01% | 1172 |
|
|
2017
Q2 | $123K | Buy |
+2,962
| New | +$113K | ﹤0.01% | 1147 |
|
Other funds holding RGEN
UCFA
VCM
VPM
MC
Oppenheimer Asset Management's RGEN Position: Q1 2026 in Review
Oppenheimer Asset Management increased its Repligen (RGEN) stake by 96% in Q1 2026, buying an estimated $2.4M and bringing the position to 35,128 shares worth $4.14M. The position accounts for 0.05% of the portfolio, ranked #373.
Oppenheimer Asset Management first reported a position in RGEN in Q2 2017 and has held it in 32 quarters since. The position peaked at $6.04M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Oppenheimer Asset Management held 35,128 shares of Repligen worth $4.14M as of Q1 2026.
- Oppenheimer Asset Management bought 17,203 Repligen shares in Q1 2026, an estimated $2.4M.
- Repligen made up 0.05% of Oppenheimer Asset Management's portfolio in Q1 2026, its #373 holding.
- Oppenheimer Asset Management first reported a position in Repligen in Q2 2017 and has held it in 32 quarters since.
- Oppenheimer Asset Management's Repligen position peaked at $6.04M in Q3 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.